Connor Landgraf is a co-founder and current CEO of Eko. He founded Eko while studying bioengineering at UC Berkeley with the intention of improving cardiovascular and pulmonary disease monitoring through the use of machine learning and non-invasive sensors. Eko became the youngest team to receive FDA clearance for a medical device, and today, Eko technology is used by hundreds of thousands of clinicians to more effectively screen millions of patients around the world for cardiac and pulmonary disease in-person and through telehealth. Since its creation, Eko has built the world's largest heart sound database and is providing disease detection capabilities comparable to that of expert cardiologists in any clinician's stethoscope. Connor was recognized as a Forbes 30 under 30 honoree in 2015.